Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
- Conditions
- Cytomegalovirus RetinitisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-03-14
- Target Recruit Count
- 240
- Registration Number
- NCT00000665
- Locations
- ๐บ๐ธ
UCLA - Jules Stein Eye Institute / SOCA, Los Angeles, California, United States
๐บ๐ธNorthwestern Univ / SOCA, Chicago, Illinois, United States
๐บ๐ธUCSD - Shiley Eye Ctr / SOCA, La Jolla, California, United States
A Study of Patients With AIDS Syndrome
- Conditions
- Lymphoma, Non-HodgkinHIV InfectionsSarcoma, KaposiLymphoma, AIDS-Related
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-09-12
- Target Recruit Count
- 5000
- Registration Number
- NCT00001120
- Locations
- ๐บ๐ธ
Univ of Hawaii, Honolulu, Hawaii, United States
๐บ๐ธWillow Clinic, Menlo Park, California, United States
๐บ๐ธSan Francisco Gen Hosp, San Francisco, California, United States
A Blood Test to Look at Cells of the Immune System in Healthy Children
- Conditions
- HIV InfectionsHIV Seronegativity
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-07-30
- Target Recruit Count
- 630
- Registration Number
- NCT00001109
- Locations
- ๐บ๐ธ
North Broward Hosp District, Fort Lauderdale, Florida, United States
๐บ๐ธChildren's Hosp at Albany Med Ctr, Albany, New York, United States
๐บ๐ธCedars Sinai / UCLA Med Ctr, Los Angeles, California, United States
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Target Recruit Count
- 60
- Registration Number
- NCT00000675
- Locations
- ๐บ๐ธ
Stanford Univ School of Medicine, Stanford, California, United States
๐บ๐ธUniv of Washington, Seattle, Washington, United States
A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia
- Conditions
- Pneumonia, Pneumocystis CariniiHIV Infections
- Locations
- ๐บ๐ธ
Warner-Lambert Parke-Davis, Morris Plains, New Jersey, United States
A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2012-05-21
- Target Recruit Count
- 200
- Registration Number
- NCT00000870
- Locations
- ๐บ๐ธ
The Ohio State Univ. AIDS CRS, Columbus, Ohio, United States
๐บ๐ธBeth Israel Deaconess - East Campus A0102 CRS, Boston, Massachusetts, United States
๐บ๐ธCase CRS, Cleveland, Ohio, United States
Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients
- Conditions
- HIV InfectionsChickenpox
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-03-01
- Target Recruit Count
- 180
- Registration Number
- NCT00000953
- Locations
- ๐บ๐ธ
Med College of Georgia, Augusta, Georgia, United States
๐บ๐ธUCLA Med Ctr, Los Angeles, California, United States
๐บ๐ธVeterans Administration Med Ctr, Martinez, California, United States
A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Target Recruit Count
- 57
- Registration Number
- NCT00001021
- Locations
- ๐บ๐ธ
Vanderbilt Univ Hosp, Nashville, Tennessee, United States
๐บ๐ธSt Louis Univ School of Medicine, St Louis, Missouri, United States
๐บ๐ธUniv of Rochester Med Ctr, Rochester, New York, United States
Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 200
- Registration Number
- NCT00001091
- Locations
- ๐บ๐ธ
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States
๐บ๐ธState Univ of New York at Stony Brook, Stony Brook, New York, United States
๐บ๐ธChildren's Hosp of Philadelphia, Philadelphia, Pennsylvania, United States
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 140
- Registration Number
- NCT00001072
- Locations
- ๐บ๐ธ
JHU AVEG, Baltimore, Maryland, United States
๐บ๐ธVanderbilt Univ. Hosp. AVEG, Nashville, Tennessee, United States
๐บ๐ธUAB AVEG, Birmingham, Alabama, United States